| Document |
Document Title |
|
WO/2020/151623A1 |
The present invention pertains to the medical field and relates to a compound of formula (III), a stereoisomer or pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the compound, a ster...
|
|
WO/2020/151621A1 |
The present invention belongs to the field of medicine, and specifically relates to a compound of formula (I), an isomer or a pharmaceutical salt thereof. This present invention more specifically relates to a compound, a stereoisomer the...
|
|
WO/2020/151543A1 |
Disclosed are a thermally activated delayed fluorescence compound, a light emitting material and an OLED device. The thermally activated delayed fluorescence compound in the present disclosure is represented by the following general form...
|
|
WO/2020/153669A1 |
The present invention relates to a compound for an organic electric device, an organic electric device using same, and an electronic apparatus thereof. According to the present invention, high luminous efficiency, low driving voltage, an...
|
|
WO/2020/147848A1 |
Provided are a tricyclic substituted oxaspiro derivative, a preparation method therefor, and a pharmaceutical use thereof. In particular, compounds of formula (I) and formula (II) or pharmaceutically acceptable salts, stereoisomers, or s...
|
|
WO/2020/150545A1 |
Pyrazole compounds (I) for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of a pyrazole compounds, in the treatment of disorders characterized by the activation of Wnt ...
|
|
WO/2020/149710A1 |
The present invention provides: a compound represented by chemical formula 1; an organic electronic element including a first electrode, a second electrode, and an organic layer formed between the first electrode and the second electrode...
|
|
WO/2020/150113A1 |
The present invention provides compounds of Formula (I): Formula (I) wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorde...
|
|
WO/2020/149711A1 |
The present invention provides: a compound represented by chemical formula 1; an organic electric element comprising a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrod...
|
|
WO/2020/149656A1 |
The present invention provides a novel compound and an organic light-emitting diode using same.
|
|
WO/2020/145508A1 |
The present invention relates to: a compound for an organic optoelectronic device, represented by chemical formula 1; and an organic optoelectronic device and a display device which comprise the compound. The description of chemical form...
|
|
WO/2020/143593A1 |
A dosing regimen of a bicyclic substituted pyrazolone azo derivative. In particular, the present invention relates to a method for treating a disease, comprising administering to a patient an effective amount of a compound represented by...
|
|
WO/2020/142227A1 |
The present disclosure provides compounds represented by Formula (I): A-L-B and the salts or solvates thereof, wherein A, L, and B are as defined in the specification. Compounds having Formula I are estrogen receptor degraders useful for...
|
|
WO/2020/140894A1 |
The present invention relates to fluorine-containing substituted benzothiophene compound, and a pharmaceutical composition and an application thereof. Specifically, the compound of the present invention has the structure as shown in form...
|
|
WO/2020/138944A1 |
The present specification relates to a polycyclic compound represented by chemical formula 1, and an organic light emitting device comprising same.
|
|
WO/2020/135488A1 |
The present invention relates to a 2,4-diaminopyrimidine derivative, pharmaceutically acceptable salts thereof, hydrates, solvates or stereoisomers, and a preparation method thereof and an application of the compound used separately or i...
|
|
WO/2020/138945A1 |
The present invention relates to a compound represented by chemical formula 1, an organic optoelectronic diode, and a display device.
|
|
WO/2020/139001A1 |
The present invention provides a novel aryl-substituted aminomethyloxetenyl amino alcohol derivative or a pharmaceutically acceptable salt thereof. More specifically, the derivative has an effect of promoting ATP production and as such, ...
|
|
WO/2020/138814A1 |
The present invention pertains to: a compound represented by a specific chemical formula; an organic optoelectronic diode; and a display device.
|
|
WO/2020/133092A1 |
The present invention relates to the technical field of agricultural chemicals, and in particular, to a pyridyloxy-carboxylate derivative and a preparation method therefor, a herbicidal composition, and use. The pyridyloxy-carboxylate de...
|
|
WO/2020/133090A1 |
The present invention relates to the technical field of pesticides, and in particular to a pyridyloxy thioester derivative and a preparation method therefor, a herbicidal composition, and an application. The pyridyloxy thioester derivati...
|
|
WO/2020/135686A1 |
Disclosed by the present invention are an organic compound with a carbazole derivative as the core and a preparation method therefor and an application thereof, which relate to the technical field of semiconductors. The structure of the ...
|
|
WO/2020/138732A1 |
The present invention provides: a compound represented by chemical formula 1; an organic electric device comprising a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrode...
|
|
WO/2020/135235A1 |
The present invention pertains to the technical field of pesticides, and specifically relates to an R-type pyridyloxycarboxylic acid, a salt and an ester derivative thereof, and a preparation method therefor, and a herbicidal composition...
|
|
WO/2020/133091A1 |
The present invention belongs to the technical field of pesticides, and in particular relates to a pyridyloxy carboxylate derivative, a preparation method therefor, a herbicidal composition and use thereof. The pyridyloxy carboxylate der...
|
|
WO/2020/134138A1 |
The present disclosure relates to the technical field of luminescent materials, and relates in particular to an organic electroluminescent compound, a preparation method therefor and an organic electroluminescent device. In order to solv...
|
|
WO/2020/131689A1 |
Provided herein is a compound of Formula (I), or a salt thereof, wherein R1 is a moiety having the following structure: (II) wherein Z is selected from the group consisting of O and N; X is selected from the group consisting of a bond, N...
|
|
WO/2020/130528A1 |
The present specification relates to a compound of chemical formula 1 and an organic light emitting diode comprising same.
|
|
WO/2020/130327A1 |
The present invention provides a novel compound and an organic light-emitting device using same.
|
|
WO/2020/127259A2 |
The present application concerns compounds for use in electronic devices, processes for preparing the compounds, and electronic devices comprising the compounds.
|
|
WO/2020/132278A1 |
The present invention concerns the use of compounds and compositions for the treatment or prevention of Flavivirus infections, such as dengue virus infections and Zika virus infections. Aspects of the invention include methods for treati...
|
|
WO/2020/127960A1 |
The present invention relates to disubstituted alkyne derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.
|
|
WO/2020/130725A1 |
The present invention relates to a novel compound and an organic electroluminescent device comprising same. As the compound according to the present invention is used in an organic material layer of an organic electroluminescent device, ...
|
|
WO/2020/130555A1 |
The present invention relates to a novel organic compound and an organic electroluminescent diode comprising same and, more specifically, to: an organic compound which has excellent electron injection and transport ability, light-emittin...
|
|
WO/2020/127176A1 |
The present application concerns compounds for use in electronic devices, processes for preparing the compounds, and electronic devices comprising the compounds.
|
|
WO/2020/130529A1 |
The present specification relates to a compound of chemical formula 1 and an organic light emitting diode comprising same.
|
|
WO/2020/127200A1 |
The present invention relates to a compound of formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, cocrystal, tautomer, racemate, enantiomer, or diastereomer or mixture thereof Formula (I) and to pharmaceu...
|
|
WO/2020/130623A1 |
The present specification provides a compound of chemical formula 1 and an organic light-emitting device comprising same.
|
|
WO/2020/130724A1 |
The present invention relates to a novel compound having excellent light-emitting capability, and to an organic electroluminescent element which, by comprising the novel compound in one or more organic material layers, has improved prope...
|
|
WO/2020/132378A2 |
This invention, in at least some embodiments, relates to an inventive molecule, compositions comprising same, and methods of use thereof for treatment of a neurological disorder.
|
|
WO/2020/127685A1 |
The present invention relates to a compound according to formula I (I) and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositio...
|
|
WO/2020/130509A1 |
The present invention relates to a novel compound and an organic electroluminescent element comprising same. The compound according to the present invention is used for an organic material layer of an organic electroluminescent element, ...
|
|
WO/2020/130553A1 |
The present invention relates to a novel organic compound and an organic electroluminescent element comprising same, and more specifically, to an organic compound having excellent electron injection and transport ability, luminescence, a...
|
|
WO/2020/122671A1 |
The present specification relates to a compound represented by chemical formula 1 and an organic light-emitting device comprising same.
|
|
WO/2020/123277A1 |
The present invention relates to ester and phosphate prodrugs of the protein kinase inhibitor N-(2-chloro-6-methylphenyl)-2-[[2-methyl-6-((S)-3-hydroxypyr
rolidin-1- yl)pyrimidin4-yl]amino]thiazole-5-carboxarnide (compound X), stereoisom...
|
|
WO/2020/122576A1 |
The present specification relates to a heterocyclic compound represented by Chemical Formula 1, an organic light-emitting device including same, a method for manufacturing same, and a composition for an organic material layer.
|
|
WO/2020/120576A1 |
The present invention concerns inhibitors of p38α autophosphorylation, pharmaceutical compositions comprising them, and their use in the treatment of a number of diseases, such as myocardial ischemia reperfusion injury. The inhibitors s...
|
|
WO/2020/122460A1 |
The present invention pertains to: a compound which is for an organic optoelectronic diode and represented by chemical formula 1; and an organic optoelectronic diode and a display device which comprise the compound. Details of chemical f...
|
|
WO/2020/122118A1 |
Provided is an organic EL element that comprises a positive electrode, a negative electrode, and a light emitting layer between the positive electrode and the negative electrode, wherein the light emitting layer includes a delayed fluore...
|
|
WO/2020/122384A1 |
The present specification provides a compound represented by chemical formula 1 and an organic light emitting device comprising same.
|
